PFS, OS or toxicity: what is the most important factor in the treatment of EGFR-mutated lung cancer?

Affiliations

• ¹ Department of Pulmonary Medicine, Mie Chuo Medical Center, Tsu City, Mie, Japan; Department of Pulmonary and Critical Care Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan. Electronic address: [email protected].
• ² Department of Pulmonary and Critical Care Medicine, Mie University Graduate School of Medicine, Tsu, Mie, Japan.